ClinicalTrials.Veeva

Menu

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module (OLD-NH-QC-DeMo)

A

Anne Niquille

Status

Completed

Conditions

Polypharmacy
Inappropriate Prescribing

Treatments

Other: Quality Circle Deprescribing Module

Study type

Interventional

Funder types

Other

Identifiers

NCT03688542
OLD-NH-QC-DeMo-2017

Details and patient eligibility

About

Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments.

The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.

Enrollment

56 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Nursing homes taking part in the study must have

  • a geriatric of psycho-geriatric mission;
  • been part of their cantonal pharmaceutical assistance program for at least a year.

Exclusion criteria

  • None

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Intervention
Experimental group
Description:
Nursing Homes allocated to the Intervention arm will enact the Quality Circle Deprescribing Module and create a local deprescribing consensus and implementation strategy.
Treatment:
Other: Quality Circle Deprescribing Module
Control
No Intervention group
Description:
Nursing Homes allocated to the Control arm will not enact the intervention.

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems